Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT05960955 · RECRUITING
Trial details
- NCT number
- NCT05960955
- Sponsor
- Akeso
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-13
- Primary completion
- 2024-11-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.